LINTAB-M 2.5

Description

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE is a combination medication used to treat type 2 diabetes. It contains two active ingredients: linagliptin and metformin hydrochloride. Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which helps to lower blood sugar levels by increasing the amount of insulin produced by the pancreas. Metformin hydrochloride is a biguanide, which works by decreasing the amount of glucose produced by the liver and increasing insulin sensitivity in the body.

Direction of Use:

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE should be taken as directed by a healthcare professional. It is usually taken twice a day, with or without food. The dose may be adjusted based on the patient’s blood sugar levels and response to treatment.

Contraindication:

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE is contraindicated in patients with severe kidney or liver disease, metabolic acidosis, or a history of lactic acidosis. It should also be avoided in patients who are allergic to linagliptin or metformin hydrochloride.

Doses and Administration:

The recommended starting dose of LINAGLIPTIN AND METFORMIN HYDROCHLORIDE is 5 mg of linagliptin and 500 mg of metformin hydrochloride twice a day. The maximum dose is 5 mg of linagliptin and 2000 mg of metformin hydrochloride twice a day.

Side Effects:

Common side effects of LINAGLIPTIN AND METFORMIN HYDROCHLORIDE include nausea, diarrhea, and stomach upset. Rare but serious side effects include lactic acidosis and kidney problems.

Interactions:

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE may interact with other medications, such as insulin, sulfonylureas, and thiazolidinediones. It is important to inform your healthcare provider of all medications you are taking before starting treatment with LINAGLIPTIN AND METFORMIN HYDROCHLORIDE.

Warnings and Precautions:

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE should be used with caution in patients with a history of kidney or liver disease. It should also be used with caution in elderly patients and in patients with a history of alcohol abuse. It is important to regularly monitor blood sugar levels and kidney function while taking LINAGLIPTIN AND METFORMIN HYDROCHLORIDE.